clinical / clinicalCardio-Oncology

Teresa Lopez-Fernandez

特蕾莎·洛佩斯-费尔南德斯

MD, PhD

🏢La Paz University Hospital, Universidad Autónoma de Madrid(拉巴斯大学医院，马德里自治大学)🌐Spain

Head, Cardio-Oncology Unit; Associate Professor of Cardiology心脏肿瘤学单元主任；心脏病学副教授

h-index

Key Papers

Awards

Key Contributions

👥Biography 个人简介

A leading European cardio-oncologist at La Paz University Hospital in Madrid who has been instrumental in developing the ESC cardio-oncology guidelines and advancing cardiovascular care for cancer patients across Spain and Europe. Her research integrates multimodality imaging with patient-centered survivorship care.

🧪Research Fields 研究领域

ESC Cardio-Oncology Guidelines欧洲心脏病学会心脏肿瘤学指南

Cardiovascular Toxicity Survivorship Spain西班牙心血管毒性幸存者研究

Multimodality Cardiac Imaging Oncology肿瘤学多模态心脏影像

🎓Key Contributions 主要贡献

ESC Cardio-Oncology Guidelines

Served as a key author of the 2022 ESC Cardio-Oncology Guidelines, contributing expertise in imaging surveillance, baseline cardiovascular risk stratification, and radiation-induced heart disease management.

Cardio-Oncology in Spain

Founded and led Spain's premier cardio-oncology unit at La Paz University Hospital, establishing national protocols and training programs that have elevated cardiovascular care for Spanish cancer patients.

Representative Works 代表性著作

[1]

Cardiotoxicity Surveillance in Cancer Patients: European Perspectives

European Heart Journal (2023)

Multinational European study evaluating imaging-based cardiotoxicity surveillance protocols and outcomes in cancer patients receiving modern therapies.

[2]

Cardio-Oncology: The Spanish Registry Experience

Revista Española de Cardiología (2021)

National registry analysis of cardiovascular complications in cancer patients treated at Spanish academic medical centers.

🏆Awards & Recognition 奖项与荣誉

🏆Spanish Society of Cardiology Young Investigator Award

🏆European Society of Cardiology Cardio-Oncology Recognition Award

🏆La Paz University Hospital Excellence in Clinical Research Prize

📄Data Sources 数据来源

Institution

Last updated: 2026-01-15 | All information from publicly available academic sources

Related Experts 相关专家

Hope S. Rugo

University of California, San Francisco (UCSF)

Antibody-Drug Conjugates in Metastatic Breast CancerASCENT Trial and Sacituzumab Govitecan

Maryam B. Lustberg

Yale School of Medicine / Yale Cancer Center

Cardiotoxicity of CDK4/6 Inhibitors and Endocrine TherapyCancer Treatment-Related Cardiovascular Disease

Sara M. Tolaney

Dana-Farber Cancer Institute / Harvard Medical School

T-DM1 and KATHERINE Trial in Residual Disease After Neoadjuvant TherapyTrastuzumab Deruxtecan (T-DXd) and DESTINY-Breast Trials

Carlos H. Barrios

PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil

CDK4/6 Inhibitors in Low- and Middle-Income Countries (LMIC)Global Breast Cancer Clinical Trials and Access

关注特蕾莎·洛佩斯-费尔南德斯的研究动态

Follow Teresa Lopez-Fernandez's research updates

留下邮箱，当我们发布与 Teresa Lopez-Fernandez（La Paz University Hospital, Universidad Autónoma de Madrid）相关的新研究或访谈时，我们会通知你。

Explore More Experts

Discover the researchers shaping the future of cancer treatment

Browse All Experts Read Research Insights

International Translational Oncology Exchange